Address And Details

601 Congress Street , Boston, MA 02210-2805
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

John Hancock Short Duration Credit Opportunities Fund seeks total return by investing in bonds and related investments and maintain an average portfolio duration of 3 years or less. The Fund's benchmark is Bloomberg Barclays 1-5 Year U.S. Credit Index.

Net Asset Value

as of 5:10 PM ET 09/27/2021


  • 1 Week
  • -0.10%
  • 1 Month
  • -0.21%
  • 3 Months
  • -0.82%
  • 1 Yr Return
  • +2.96%
  • 5 Yr Return
  • +1.25%

Equity Sector Breakdown

ConsumerDurables n/a
Energy n/a
Finance n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Bonds 94.89%
Cash 3.53%
Other 1.58%
Stocks 0.01%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 55.30 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 1.62 1.75 1.73
Beta 0.52 0.43 0.39
R Squared 0.06 0.06 0.06
Std Deviation 7.31 5.80 4.88
Sharpe Ratio 0.54 0.46 n/a

Purchase Information

as of 5:20 PM ET 09/23/2021
Minimum Initial $250000
Minimum Additional $0
Minimum Initial IRA $0


Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 05/31/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 05/31/2021
1 Year
  • +5.00%
  • +10.39%
+5.00% +10.39%
3 Year
  • +4.79%
  • +4.60%
+4.79% +4.60%
10 Year
  • +3.43%
  • +3.14%
+3.43% +3.14%
Life Of Fund
  • +3.65%
  • +3.73%
+3.65% +3.73%

Top 10 Holdings

Symbol Company Name % Of Assets

Recent Articles from TheStreet

Chewy Pet Food Lead

Chewy Lifted to Outperform; Wolfe Sees 'Strong Growth Ahead'

Wolfe Research upgraded Chewy to outperform, saying a drop in net new customer additions should reverse in fiscal 2022.

Meditating on the Toilet and 7 Other Ways to Relax at Work

The Questions Investors Should be Asking Themselves

Ahead of third-quarter earnings season, James 'Rev Shark' Deporre has some thoughts on what investors should be thinking about.

iPhone Apple Lead

Will a Market Correction Make Apple Stock a Buy?

Apple stock is trying to hold up, but is struggling amid the market correction. Here's where support may come into play.

Gogo Inflight Internet Lead

5 Top Stock Gainers for Tuesday: Gogo, Huntsman, Thor Industries

Gogo, Huntsman, Thor Industries, United Natural Foods and Sonoma Pharmaceuticals are five top stock gainers for Tuesday.

Hong Kong Stocks Slide As Virus Fears Roil Markets While China Dents Hopes For Policy Easing

Dow Falls 400 Points as Bond Yields Surge, Energy Crisis Rattles Markets

Stocks are lower as Wall Street contends with rolling blackouts in China, record high energy prices in Europe and gas line-ups in Britain.

Aurora Cannabis Raises $345 Million Through Debt Offering

Aurora Cannabis Stock Rises; Cowen Affirms Market Perform

Aurora Cannabis had a tough quarter, but Cowen analysts still expect strong growth margins in 2022.

The New Ford Maverick

How Far Can Ford Stock Rally Right Now?

Ford stock still trades well on the long side. It may be time to book some profit and raise our stop-loss on this great trade, while looking for more upside.

Redwire Lead

Spacecraft-Design Firm Redwire Stock Higher; Initiated Buy at Jefferies

'Redwire offers a diversified portfolio of space components that are well-positioned to capture emerging trends,' Jefferies says.

Frothy Stock Market Lead

Federated Hermes's Orlando, a Noted Bull, Sees 10% Stock Correction

Uncertain fiscal and monetary policies could prompt a stock correction, the noted bull Phil Orlando says.

Sanofi Strikes $11.6 Billion Deal for Bioverativ

Sanofi Drops mRNA COVID Vaccine Plans Due to Saturated Market

Sanofi says its COVID vaccine candidate has positive test results, but the company is ready to drop its development because of the Moderna and Pfizer vaccines.